TY  - ADVS
AU  - Hauser,Robert A.
TI  - Promising medical therapies for Parkinson's disease
T2  - Parkinson's disease,
PY  - 2014///
CY  - London
PB  - Henry Stewart Talks
KW  - Antiparkinsonian agents
KW  - Side effects
KW  - Dopa
KW  - Physiological effect
KW  - Parkinson's disease
KW  - Chemotherapy
KW  - Treatment
KW  - Adenosine A2 Receptor Antagonists
KW  - Antiparkinson Agents
KW  - adverse effects
KW  - therapeutic use
KW  - Apomorphine
KW  - pharmacokinetics
KW  - Benzylamines
KW  - Dopamine Agonists
KW  - Dyskinesia, Drug-Induced
KW  - prevention & control
KW  - Levodopa
KW  - Parkinson Disease
KW  - drug therapy
KW  - therapy
KW  - Receptor, Metabotropic Glutamate 5
KW  - antagonists & inhibitors
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Selected Future Therapies for Motor Fluctuations and Dyskinesias -- Ankiparkinsonian agents -- A2a antagonists -- Levodopa preparations -- VR040 (inhaled apomorphine) -- Safinamide (mixed MOA : MAO-B and glu inhibition) -- Anti-dyskinetics -- AFQ056 : mGluR5 antagonist -- ADX48621 (dipraglurant) : mGluR5 negative allosteric modulator -- Fipamezole :a2 adrengergic receptor antagonist -- ADS-5102 : sustained release amantadine; Access restricted to subscribers
UR  - https://hstalks.com/bs/2817/
UR  - https://hstalks.com/bs/p/805/
ER  -